BioTek Expands in the United Kingdom
News Jun 05, 2015
BioTek Instruments, Inc. expands their ongoing investment in the European microplate-based technology market with the opening of their new UK Office in Swindon. Mr. Dominic Herring, previously BioTek’s Business and Development Manager with BioTek Singapore, was named General Manager. The new office will focus on bringing enhanced applications and technical support to current and future customers in the United Kingdom.
"The UK’s biotechnology and life scientific sectors are growing; supported by the government’s focus and investment," noted Dominic Herring, BioTek’s UK General Manager. "Our new and expanded direct office in Swindon will allow us to provide local, comprehensive and immediate sales, applications and service support to our rapidly increasing customer base in a market that continues to demonstrate high quality scientific research." BioTek UK is now fully functional and will house administration, sales, service, technical support, training and a complete supplies inventory.
"The establishment of our new BioTek UK Office will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing local service and applications support, our customers in the UK will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced satisfaction for our customers."
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE
Sciformix Corporation Collaborates with Oracle Health SciencesNews
New collaboration enables faster and more informed drug safety decisions.READ MORE
Quotient Sciences Launches as the New Global Identity for Quotient ClinicalNews
Quotient is focused on delivering a portfolio of innovative services encompassing formulation development, clinical trial and commercial manufacturing, and clinical pharmacology.READ MORE